JP2021143172A - Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like - Google Patents
Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like Download PDFInfo
- Publication number
- JP2021143172A JP2021143172A JP2020204722A JP2020204722A JP2021143172A JP 2021143172 A JP2021143172 A JP 2021143172A JP 2020204722 A JP2020204722 A JP 2020204722A JP 2020204722 A JP2020204722 A JP 2020204722A JP 2021143172 A JP2021143172 A JP 2021143172A
- Authority
- JP
- Japan
- Prior art keywords
- pathogen
- fungus
- parasite
- bacterium
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000052769 pathogen Species 0.000 title claims abstract description 15
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 13
- 241000894006 Bacteria Species 0.000 title claims abstract description 12
- 241000233866 Fungi Species 0.000 title claims abstract description 12
- 241000700605 Viruses Species 0.000 title claims abstract description 12
- 244000045947 parasite Species 0.000 title claims abstract description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 4
- 230000001717 pathogenic effect Effects 0.000 title abstract description 7
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 230000003449 preventive effect Effects 0.000 claims description 5
- 239000000645 desinfectant Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims 1
- 230000036425 denaturation Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003398 denaturant Substances 0.000 abstract description 13
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 2
- 239000001257 hydrogen Substances 0.000 abstract description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 3
- 108020004414 DNA Proteins 0.000 abstract 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 1
- 102000053602 DNA Human genes 0.000 abstract 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 6
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- -1 hydrogen ions Chemical class 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
本発明は、細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止する薬剤に関する。 The present invention relates to agents that stop the function of pathogens of infectious diseases such as bacteria, viruses, fungi and parasites.
細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止する薬剤がない。 There are no drugs that stop the function of pathogens of infectious diseases such as bacteria, viruses, fungi and parasites.
細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止する薬剤を提供することを目的とする。 It is an object of the present invention to provide a drug that stops the function of a pathogen of an infectious disease such as a bacterium, a virus, a fungus, or a parasite.
本発明の目的を達成するため、次の構成を採用する。
細菌、ウイルス、真菌、寄生虫などの感染症の病原体は、核酸を持っている。
核酸とは、DNAとRNAのことである。
DNAとRNAは塩基間で水素結合しているが、変性剤を加えてアルカリ性にすると、水素イオンを放出するため変性し、DNAとRNAの二重らせんが１本鎖ごと２本に分離する。
変性剤を加えてDNAとRNAを壊すことにより、細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止する。
In order to achieve the object of the present invention, the following configuration is adopted.
Pathogens of infectious diseases such as bacteria, viruses, fungi and parasites carry nucleic acids.
Nucleic acids are DNA and RNA.
DNA and RNA are hydrogen-bonded between bases, but when they are made alkaline by adding a denaturant, they are denatured to release hydrogen ions, and the double helix of DNA and RNA is separated into two single strands.
By adding denaturants to destroy DNA and RNA, the function of pathogens of infectious diseases such as bacteria, viruses, fungi, and parasites is stopped.
変性剤という細菌、ウイルス、真菌、寄生虫などの感染症の病原体の治療薬を人体に投与するか皮膚にぬり、病原体の機能を停止することにより感染症を治療する。
感染症が発生する前に、変性剤という感染症の予防薬を人体に投与して、体内に蓄積されると、細菌、ウイルス、真菌、寄生虫などの感染症の病原体に汚染された時に、病原体の機能を停止することにより感染症を予防する。さらに予防薬をうがいして感染症を予防する。
変性剤という感染症の消毒薬を使用して、細菌、ウイルス、真菌、寄生虫などの感染症の病原体の機能を停止することにより消毒する。
農産物や樹木や花などの植物の場合や、魚貝類や畜産動物などの動物の場合も同様に、変性剤という感染症の病原体の治療薬を投与することにより、感染症を治療する。さらに、感染症が発生する前に変性剤を投与して、感染症を予防する。さらに、変性剤という感染症の消毒薬を使用して、消毒する。
Infectious diseases are treated by administering a therapeutic agent for a pathogen of an infectious disease such as a bacterium, a virus, a fungus, or a parasite called a denaturant to the human body or applying it to the skin to stop the function of the pathogen.
Before an infectious disease occurs, a denaturer, a preventive drug for infectious diseases, is administered to the human body, and when it accumulates in the body, it becomes contaminated with pathogens of infectious diseases such as bacteria, viruses, fungi, and parasites. Prevent infectious diseases by stopping the function of pathogens. In addition, gargling preventive drugs to prevent infectious diseases.
Disinfectants are used to disinfect infectious diseases by stopping the function of pathogens of infectious diseases such as bacteria, viruses, fungi, and parasites.
Similarly, in the case of agricultural products, plants such as trees and flowers, and animals such as fish and shellfish and livestock animals, the infectious disease is treated by administering a therapeutic agent for the pathogen of the infectious disease called a denaturer. In addition, a denaturant is administered before the infection occurs to prevent the infection. In addition, it is disinfected using an infectious disease disinfectant called a denaturant.
変性剤という感染症の治療薬を飲み薬として飲むか、注射により投与する。
皮膚の感染症の場合、変性剤を皮膚にぬる。
変性剤という感染症の予防薬を感染症が発生する前に飲み薬として飲むか、注射により投与する。
変性剤という感染症の予防薬をうがい薬として、うがいする。
変性剤という感染症の消毒薬を手洗いに使用する、机などの接触面に散布する、空気中に散布する、などをして消毒する。
農産物や樹木や花などの植物の場合、植物が芽を出す前からの根の部分に、肥料を加えるのと同様の方法で、変性剤を加えるか、変性剤を葉面散布して、植物全体に加えるか、植物に直接変性剤を注射で注入するなどの方法がある。
魚貝類や畜産動物などの動物の場合、動物の餌に変性剤を加えるか、動物に直接変性剤を注射で注入するなどの方法がある。
A denaturant, a remedy for infectious diseases, is taken as a swallow or given by injection.
For skin infections, apply a denaturant to the skin.
A denaturer, a preventive drug for infectious diseases, is taken as a swallow or given by injection before the outbreak of the infectious disease.
Gargle with a denaturer, a preventive drug for infectious diseases, as a mouthwash.
Disinfect by using a disinfectant for infectious diseases called a denaturant for hand washing, spraying on a contact surface such as a desk, or spraying in the air.
In the case of plants such as agricultural products, trees and flowers, the plant is added with a modifier or foliar sprayed with a modifier in the same way as adding fertilizer to the root part before the plant sprouts. There are methods such as adding to the whole or injecting the denaturant directly into the plant.
In the case of animals such as fish and shellfish and livestock animals, there are methods such as adding a denaturant to the animal's diet or injecting the denaturant directly into the animal by injection.
Claims (3)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020045838 | 2020-02-27 | ||
| JP2020045838 | 2020-02-27 | ||
| JP2020067896 | 2020-03-17 | ||
| JP2020067896 | 2020-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2021143172A true JP2021143172A (en) | 2021-09-24 |
Family
ID=77765901
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020110919A Pending JP2021143169A (en) | 2020-02-27 | 2020-06-01 | Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like |
| JP2020204722A Pending JP2021143172A (en) | 2020-02-27 | 2020-12-10 | Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020110919A Pending JP2021143169A (en) | 2020-02-27 | 2020-06-01 | Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP2021143169A (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005170797A (en) * | 2003-12-08 | 2005-06-30 | Kokusai Irin Seika Kagi Kofun Yugenkoshi | Antibacterial, antiviral and antifungal composition and method for producing the same |
| JP2011231087A (en) * | 2010-04-30 | 2011-11-17 | Nihon Univ | Antiviral agent having photosensitive substance as active ingredient |
| JP5630679B1 (en) * | 2013-09-08 | 2014-11-26 | 株式会社Ｅ・テック | Volatile disinfectant and method for producing volatile disinfectant |
| WO2018136396A2 (en) * | 2017-01-18 | 2018-07-26 | Excision Biotherapeutics, Inc. | Crisprs |
-
2020
- 2020-06-01 JP JP2020110919A patent/JP2021143169A/en active Pending
- 2020-12-10 JP JP2020204722A patent/JP2021143172A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021143169A (en) | 2021-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2414902C1 (en) | Bactericidal composition for prevention and treatment of infectious diseases of hoofs in animals | |
| JP2021143172A (en) | Pharmaceutical agent for stopping function of pathogen of infection disease caused by bacterium, virus, fungus, parasite or the like | |
| Adegbeye et al. | Potential of silver nanoparticles for veterinary applications in livestock performance and health | |
| BR9913990A (en) | Use of organophosphate compounds for the production of pharmaceutical preparations for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide in plants | |
| Adinortey et al. | Honey as a natural product worthy of Re-consideration in treating MRSA wound infections | |
| CN1031654A (en) | Prevention and treatment are by the medicament composition of antibacterial or the viral disease that causes | |
| Muahiddah et al. | The Use Of Immunostimulants From Papaya Leaves To Treat Disease And Increase Non-Specific Immunity In Fish And Shrimp | |
| JP2022151436A (en) | Agents for treating meningitidis and encephalitis | |
| US11744249B2 (en) | Disinfectants with iodine and copper complexes for use against coronavirus | |
| JP2022140193A (en) | Therapeutic agent for rheumatic diseases | |
| JP2022151426A (en) | Agents for treating upper respiratory inflammation | |
| JP2022151439A (en) | Agents for treating rhinitis | |
| JP2022151437A (en) | Agents for treating retinitis | |
| US20230389553A1 (en) | Disinfectants with iodine and copper complexes for biofilm eradication and prevention | |
| JP2022151427A (en) | Agents for treating esophagitis | |
| JP2022151440A (en) | Agents for treating arthritis | |
| JP2022140194A (en) | Therapeutic agent for connective tissue diseases | |
| RU2180221C2 (en) | Method to treat subclinical mastitis in cows | |
| JP2022151431A (en) | Agent for treating enteritis | |
| El-Shafaey et al. | Phenytoin: A promising non-antibiotic drug for the topical treatment of digital dermatitis in dairy cows, Veterinary World, 14 (11): 2907-2912 | |
| JP2022124985A (en) | Pneumonia therapeutic drugs | |
| JP2022140190A (en) | Therapeutic agent for autoimmune diseases | |
| JP2022146830A (en) | Therapeutic agent for retinal detachment | |
| Ashraf et al. | Infections | |
| JP2022151428A (en) | Agent for treating nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210327 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230623 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231121 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20240604 |